Roman Shimanovich
About Roman Shimanovich
Roman Shimanovich is a Senior Principal Scientist with extensive experience in pharmaceutical research, currently holding positions at Schrödinger, Bristol-Myers Squibb, and Celgene.
Current Role at Schrödinger
Roman Shimanovich currently serves as Director at Schrödinger in New York, New York, United States. His role involves leading scientific initiatives, aligning with the company’s goals in the realm of computational chemistry and software development for drug discovery.
Position at Bristol-Myers Squibb
Roman Shimanovich holds the position of Senior Principal Scientist at Bristol-Myers Squibb in Boston, Massachusetts, United States. His responsibilities include advancing pharmaceutical research and development, focusing on improving preclinical formulations and biochemical processes pertaining to drug candidates.
Work at Celgene
Roman Shimanovich is also a Senior Principal Scientist at Celgene, located in Cambridge, Massachusetts, United States. In this role, he contributes his expertise in solid state characterization and preclinical formulation development to support Celgene's pharmaceutical projects.
Previous Experience at Amgen
Between 2015 and 2018, Roman Shimanovich worked as a Principal Scientist at Amgen in Thousand Oaks, California, United States. Prior to this, he was a Senior Scientist at the same company from 2008 to 2015. During his tenure, he focused on chemical degradation and kinetic studies, particularly in oxidation reaction mechanisms.
Academic Background
Roman Shimanovich earned his PhD in Chemistry from Princeton University, studying from 1997 to 2003. Before that, he completed his undergraduate studies at the Massachusetts Institute of Technology (MIT), obtaining a BS in Chemistry and Biology from 1993 to 1997. His academic background laid a foundation for his extensive expertise in the chemical sciences.